Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis

NCT07283887 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Denosumab
DRUG: Romosozumab

Sponsor

National Taiwan University Hospital